中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/11/24 | 5,000 | 5,105 | 5,000 | 5,073 | +133 | +2.7% | 2,942,000 |
| 2023/11/22 | 4,850 | 4,978 | 4,835 | 4,940 | +104 | +2.2% | 2,071,100 |
| 2023/11/21 | 4,856 | 4,876 | 4,770 | 4,836 | -44 | -0.9% | 2,695,400 |
| 2023/11/20 | 4,890 | 4,930 | 4,870 | 4,880 | -23 | -0.5% | 1,928,900 |
| 2023/11/17 | 4,749 | 4,906 | 4,745 | 4,903 | +148 | +3.1% | 2,434,100 |
| 2023/11/16 | 4,718 | 4,755 | 4,690 | 4,755 | +12 | +0.3% | 2,194,000 |
| 2023/11/15 | 4,761 | 4,787 | 4,680 | 4,743 | +36 | +0.8% | 2,422,500 |
| 2023/11/14 | 4,746 | 4,749 | 4,651 | 4,707 | -13 | -0.3% | 1,541,800 |
| 2023/11/13 | 4,716 | 4,743 | 4,672 | 4,720 | +42 | +0.9% | 1,614,200 |
| 2023/11/10 | 4,708 | 4,729 | 4,603 | 4,678 | -91 | -1.9% | 2,241,700 |
| 2023/11/09 | 4,668 | 4,782 | 4,636 | 4,769 | +116 | +2.5% | 2,158,700 |
| 2023/11/08 | 4,667 | 4,727 | 4,634 | 4,653 | +1 | ±0% | 3,100,800 |
| 2023/11/07 | 4,670 | 4,719 | 4,635 | 4,652 | -37 | -0.8% | 1,842,700 |
| 2023/11/06 | 4,708 | 4,719 | 4,654 | 4,689 | +72 | +1.6% | 2,213,700 |
| 2023/11/02 | 4,604 | 4,640 | 4,578 | 4,617 | -9 | -0.2% | 1,568,800 |
| 2023/11/01 | 4,592 | 4,639 | 4,564 | 4,626 | +166 | +3.7% | 2,215,300 |
| 2023/10/31 | 4,358 | 4,475 | 4,331 | 4,460 | +108 | +2.5% | 2,236,100 |
| 2023/10/30 | 4,409 | 4,435 | 4,259 | 4,352 | -116 | -2.6% | 1,837,300 |
| 2023/10/27 | 4,244 | 4,487 | 4,234 | 4,468 | +143 | +3.3% | 2,278,800 |
| 2023/10/26 | 4,408 | 4,446 | 4,306 | 4,325 | -83 | -1.9% | 2,365,700 |
| 2023/10/25 | 4,451 | 4,528 | 4,398 | 4,408 | +9 | +0.2% | 2,635,800 |
| 2023/10/24 | 4,475 | 4,488 | 4,325 | 4,399 | -120 | -2.7% | 2,190,900 |
| 2023/10/23 | 4,548 | 4,556 | 4,489 | 4,519 | -29 | -0.6% | 1,548,900 |
| 2023/10/20 | 4,575 | 4,595 | 4,502 | 4,548 | -65 | -1.4% | 2,110,700 |
| 2023/10/19 | 4,617 | 4,698 | 4,593 | 4,613 | -48 | -1% | 1,783,900 |
| 2023/10/18 | 4,571 | 4,673 | 4,563 | 4,661 | -50 | -1.1% | 2,002,700 |
| 2023/10/17 | 4,663 | 4,713 | 4,644 | 4,711 | +87 | +1.9% | 1,580,200 |
| 2023/10/16 | 4,703 | 4,708 | 4,602 | 4,624 | -71 | -1.5% | 1,547,700 |
| 2023/10/13 | 4,715 | 4,730 | 4,635 | 4,695 | -46 | -1% | 2,306,600 |
| 2023/10/12 | 4,645 | 4,741 | 4,630 | 4,741 | +156 | +3.4% | 2,996,400 |
| 2023/10/11 | 4,552 | 4,622 | 4,541 | 4,585 | +36 | +0.8% | 1,760,900 |
| 2023/10/10 | 4,500 | 4,568 | 4,439 | 4,549 | +115 | +2.6% | 1,649,800 |
| 2023/10/06 | 4,425 | 4,483 | 4,415 | 4,434 | +8 | +0.2% | 1,321,300 |
| 2023/10/05 | 4,381 | 4,426 | 4,321 | 4,426 | +35 | +0.8% | 2,112,100 |
| 2023/10/04 | 4,450 | 4,450 | 4,389 | 4,391 | -110 | -2.4% | 2,332,200 |
| 2023/10/03 | 4,550 | 4,581 | 4,470 | 4,501 | -33 | -0.7% | 2,230,200 |
| 2023/10/02 | 4,624 | 4,701 | 4,528 | 4,534 | -90 | -1.9% | 2,485,000 |
| 2023/09/29 | 4,664 | 4,706 | 4,579 | 4,624 | +7 | +0.2% | 5,778,300 |
| 2023/09/28 | 4,451 | 4,712 | 4,446 | 4,617 | +166 | +3.7% | 5,822,300 |
| 2023/09/27 | 4,225 | 4,465 | 4,197 | 4,451 | +174 | +4.1% | 4,190,300 |
| 2023/09/26 | 4,306 | 4,359 | 4,257 | 4,277 | -22 | -0.5% | 1,972,700 |
| 2023/09/25 | 4,288 | 4,331 | 4,259 | 4,299 | +49 | +1.2% | 1,394,200 |
| 2023/09/22 | 4,217 | 4,285 | 4,211 | 4,250 | -15 | -0.4% | 1,874,900 |
| 2023/09/21 | 4,275 | 4,354 | 4,261 | 4,265 | -83 | -1.9% | 1,861,800 |
| 2023/09/20 | 4,435 | 4,454 | 4,337 | 4,348 | -110 | -2.5% | 2,153,700 |
| 2023/09/19 | 4,490 | 4,539 | 4,438 | 4,458 | -69 | -1.5% | 1,603,400 |
| 2023/09/15 | 4,480 | 4,541 | 4,433 | 4,527 | +52 | +1.2% | 2,703,000 |
| 2023/09/14 | 4,526 | 4,535 | 4,441 | 4,475 | -50 | -1.1% | 1,861,500 |
| 2023/09/13 | 4,560 | 4,567 | 4,505 | 4,525 | -23 | -0.5% | 1,350,400 |
| 2023/09/12 | 4,470 | 4,550 | 4,439 | 4,548 | +71 | +1.6% | 1,439,100 |
351～
400
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 862,000円 | +1.7% | +5.0% | 2.90% | 34.60倍 | 7.46倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 第一三共 | 370,200円 | +6.0% | +4.0% | 2.11% | 22.98倍 | 4.25倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 441,900円 | +7.7% | +206.9% | 4.44% | 59.10倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 大塚ＨＤ | 769,700円 | +2.2% | +10.2% | 1.56% | 14.78倍 | 1.49倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
